Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
OGXI > SEC Filings for OGXI > Form 8-K on 2-Jun-2014All Recent SEC Filings




Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 29, 2014, OncoGenex Pharmaceuticals, Inc. (the "Company") held its 2014 Annual Meeting at which the Company's stockholders (i) elected the six directors identified in the table below to the Board of Directors of the Company to serve until the Company's next annual meeting of stockholders or until their successors are duly elected and qualified, (ii) ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014, (iii) approved an amendment to the Company's 2010 Performance Incentive Plan to increase the total shares of common stock available for issuance under the 2010 Performance Incentive Plan from 2,050,000 to 2,800,000 and (iv) approved, by a non-binding advisory vote, a resolution approving the compensation paid by the Company to its named executive officers. Set forth below are the final voting tallies for the Company's 2014 Annual Meeting:

       Proposal: Election of Directors      For      Withheld   Broker Non-Vote
       Neil Clendeninn                   5,777,020   121,466       4,840,620
       Scott Cormack                     5,831,694    66,792       4,840,620
       Jack Goldstein                    5,785,168   113,318       4,840,620
       Martin Mattingly                  5,789,321   109,165       4,840,620
       Stewart Parker                    5,828,617    69,869       4,840,620
       David Smith                       5,827,967    70,519       4,840,620

Proposal:                                  For         Against     Abstain    Broker Non-Vote
Ratification of independent auditor     10,648,536     70,680      19,890            0
Amendment to 2010 Performance
Incentive Plan                          4,815,251     1,022,425    60,810        4,840,620
Approval of named executive officer
compensation                            5,582,171      247,913     68,402        4,840,620

  Add OGXI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for OGXI - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.